Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover wealth building funds that offer high ROI to enhance your financial strategy. Learn how to grow your wealth effectively.
25,081 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Oil prices fall, stock futures rise as reports of a U.S.-backed cease-fire plan with Iran surface, setting up a cauti...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
Paysign stock skyrocketing today has traders buzzing about a rapid move in a healthcare fintech company. This guide b...
Hyperliquid's HYPE hovers around $39 after a daily dip, but a persistent rising channel and fresh institutional acces...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
On a downbeat tech day, software stocks proved resilient as cloud demand and subscription revenue buoyed leaders like...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
The idea of a sweeping Sell America trade captured headlines for years. This article breaks down what happened, why i...
For the first time in decades, Berkshire Hathaway held its annual meeting without Warren Buffett. Executives laid out...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
International demand for live music is rising, with concert promoters reporting that international fans now outpace d...